LIMITED STAGE LUNG SMALL CELL CARCINOMA
Clinical trials for LIMITED STAGE LUNG SMALL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LIMITED STAGE LUNG SMALL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for LIMITED STAGE LUNG SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to outsmart tough lung cancer
Disease control OngoingThis study is testing if adding an experimental drug called berzosertib (M6620) to standard chemotherapy (topotecan) works better than chemotherapy alone for adults whose small cell lung cancer has come back. The goal is to see if the combination can help control the cancer for l…
Matched conditions: LIMITED STAGE LUNG SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Major cancer trial tests if adding Immune-Boosting drug helps patients live longer
Disease control OngoingThis large study is testing whether adding an immunotherapy drug (atezolizumab) to standard chemotherapy and radiation treatment helps people with early-stage small cell lung cancer live longer. About 544 patients will be randomly assigned to receive either the standard treatment…
Matched conditions: LIMITED STAGE LUNG SMALL CELL CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Scientists test Triple-Threat attack on Tough-to-Treat lung cancer
Disease control OngoingThis early-stage study is testing the safety and best dose of a new three-drug combination for small cell lung cancer that has returned after initial treatment. The combination includes a pill (tazemetostat), a chemotherapy (topotecan), and an immunotherapy (pembrolizumab), aimin…
Matched conditions: LIMITED STAGE LUNG SMALL CELL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC